Abstract and Introduction
Introduction
Transgender individuals experience a self-concept of gender that differs from their sex assigned at birth.[1] A transgender female self identifies as female and has been assigned male sex at birth (male-to-female). A transgender male self identifies as male and has been assigned female sex at birth (female-to-male). An estimated 1.3–2.0 million people in the United States identify as transgender; this is possibly underestimated given the lack of national census surveillance of gender identity.[2,3] Some transgender individuals may choose to undergo gender-affirming hormone (GAH) therapy or gender-affirming surgery (GAS) to align their external appearance with their inner experience of gender.
This narrative aims to introduce readers to breast-related gender-affirmation therapy, review the most recent recommendations for breast cancer screening in the transgender population, and depict some of the expected breast imaging findings in the transgender population.
Appl Radiol. 2022;51(3):24-32. © 2022 Anderson Publishing, Ltd.
